Pentagon funds rare-earth capacity while China faces supply disruptions

The Pentagon's Office of Strategic Capital committed $500 million in loan backing to a domestic rare-earth processor this week, according to Inside Defense. The timing is notable: China reported one fatality and four injuries from a magnitude 6.3 earthquake in Qinghai province, a region central to rare-earth mining and refining infrastructure, Reuters confirmed.

The loan marks the latest in a string of DOD moves to backstop critical-mineral supply chains outside Chinese control. Rare earths remain essential to defense electronics, precision munitions, and aviation systems. The U.S. still sources the majority of processed rare-earth materials from China, despite domestic mining restarts in recent years.

China also reported a separate coal-mine disaster and new Indonesian export policy shifts that roiled global coal markets, Reuters said. The twin resource disruptions—earthquake damage in a mining region and operational failures in coal—underscore the fragility of concentrated supply chains even in the world's largest commodity producer.

Elsewhere, the FDA approved Colorado's plan to import certain prescription drugs from Canada, a state-level workaround to U.S. pharmaceutical pricing. STAT reported the decision allows Colorado to source select medications at lower cost, bypassing domestic wholesale channels. The move has no direct overlap with rare-earth or energy flows, but it reflects a broader policy willingness to re-route supply when domestic markets price out end users.

The rare-earth loan, the Chinese disruptions, and the pharma import approval all point the same direction: supply-chain sovereignty is now policy, and the U.S. is willing to underwrite it with federal capital when markets won't move fast enough.